CRIS Current Research Information System

NUVOLA, GIACOMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.315
NA - Nord America 794
EU - Europa 453
AF - Africa 66
SA - Sud America 50
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.682
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 776
SG - Singapore 466
VN - Vietnam 263
CN - Cina 256
IT - Italia 115
HK - Hong Kong 92
DE - Germania 56
BD - Bangladesh 55
SE - Svezia 54
KR - Corea 52
BR - Brasile 38
IN - India 38
GB - Regno Unito 37
FR - Francia 34
NL - Olanda 30
IE - Irlanda 29
FI - Finlandia 27
CI - Costa d'Avorio 25
JO - Giordania 22
CH - Svizzera 20
JP - Giappone 19
BG - Bulgaria 18
PH - Filippine 15
RU - Federazione Russa 12
TG - Togo 12
CA - Canada 11
SC - Seychelles 11
ZA - Sudafrica 9
ID - Indonesia 7
TH - Thailandia 6
ES - Italia 5
PL - Polonia 5
LT - Lituania 4
NG - Nigeria 4
PK - Pakistan 4
AR - Argentina 3
AU - Australia 3
IL - Israele 3
TW - Taiwan 3
AL - Albania 2
AT - Austria 2
BE - Belgio 2
CL - Cile 2
CO - Colombia 2
IQ - Iraq 2
KG - Kirghizistan 2
MX - Messico 2
PE - Perù 2
SA - Arabia Saudita 2
TR - Turchia 2
UZ - Uzbekistan 2
VE - Venezuela 2
BB - Barbados 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EG - Egitto 1
HN - Honduras 1
IR - Iran 1
JM - Giamaica 1
LB - Libano 1
MA - Marocco 1
MK - Macedonia 1
MZ - Mozambico 1
OM - Oman 1
PY - Paraguay 1
SN - Senegal 1
TN - Tunisia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 2.682
Salva come PNG Salva come JPEG
Città #
Singapore 376
Ashburn 137
Hong Kong 84
Hefei 76
San Jose 73
Santa Clara 64
Hanoi 53
Ho Chi Minh City 52
Seoul 48
Beijing 43
Chandler 43
Boardman 30
Dong Ket 30
Dublin 29
Abidjan 25
Council Bluffs 24
Fairfield 23
Amman 22
Helsinki 21
Bologna 20
Bern 19
New York 18
Sofia 18
Tokyo 17
Seattle 16
Woodbridge 15
Da Nang 12
Houston 12
Lomé 12
Los Angeles 12
Princeton 12
Southend 12
São Paulo 12
Buffalo 11
Lauterbourg 11
Frankfurt am Main 10
Munich 9
Redondo Beach 9
Rome 9
Wilmington 9
Cambridge 8
Nuremberg 8
Shanghai 8
Bengaluru 7
Guangzhou 7
Hyderabad 7
Moncalieri 7
Turin 7
Biên Hòa 5
City of London 5
Jakarta 5
London 5
Turku 5
Abeokuta 4
Barnet 4
Can Tho 4
Haiphong 4
Hangzhou 4
Paris 4
Tongling 4
Toronto 4
Warsaw 4
Atlanta 3
Bari 3
Berlin 3
Boston 3
Brooklyn 3
Cape Town 3
Des Moines 3
Falkenstein 3
Genoa 3
Hải Dương 3
Johannesburg 3
Manchester 3
Milan 3
Modena 3
Mumbai 3
Pune 3
Quảng Ngãi 3
Quận Bình Thạnh 3
Roubaix 3
San Diego 3
Stockholm 3
Sydney 3
Tân Tiến 3
Verona 3
Ann Arbor 2
Bangkok 2
Bexley 2
Bishkek 2
Boydton 2
Bremen 2
Brunswick 2
Brussels 2
Bühl 2
Bắc Giang 2
Cagliari 2
Caracas 2
Changsha 2
Charlotte 2
Totale 1.748
Salva come PNG Salva come JPEG
Nome #
Comparison of Sequential Testing and Next Generation Sequencing in advanced Lung Adenocarcinoma patients – A single centre experience 275
Prognostic Factors of Survival for High-Grade Neuroendocrine Neoplasia of the Bladder: A SEER Database Analysis 229
Single-agent carboplatin in extensive disease small-cell lung cancer patient with liver failure: A case report within the experience of a single institution 181
Bone Targeting Agents in Patients with Prostate Cancer: General Toxicities and Osteonecrosis of the Jaw 165
Clinical efficacy of immune checkpoint inhibitors in patients with brain metastases 165
Adjuvant PD-1 and PD-L1 Inhibitors and Relapse-Free Survival in Cancer Patients: The MOUSEION-04 Study 163
A hypothesis-generating analysis on the role of TERT promoter mutation in advanced urothelial carcinoma treated with immunotherapy 155
Hyperammonemic encephalopathy during XELOX regimen. Is it capecitabine or oxaliplatin responsible? 147
Hypertransaminasemia in metastatic renal cell carcinoma patients receiving immune-based combinations: a meta-analysis 130
Cardiac Toxicity From Afatinib in EGFR-Mutated NSCLC: A Rare But Possible Side Effect 119
PD-(L)1 inhibitors as single-agent or in combination with chemotherapy for advanced, PD-L1-high non-small cell lung cancer: a meta-analysis 115
The molecular characteristics of non‐clear cell renal cell carcinoma: What’s the story morning glory? 112
An update on safety evaluation of immune-based combinations in patients with advanced renal cell carcinoma 103
Development and Management of Massive Subcutaneous Metastases with Unusual Clinical Course from Uterine Leiomyosarcoma 98
Treatment Options for Metastatic Urothelial Carcinoma After First-Line Chemotherapy 94
An insight on novel molecular pathways in metastatic prostate cancer: A focus on ddr, msi and akt 86
The Landscape of Immunotherapy in Advanced NSCLC: Driving Beyond PD-1/PD-L1 Inhibitors (CTLA-4, LAG3, IDO, OX40, TIGIT, Vaccines) 77
IMpower 132: Is the Second Exception to the Rule No Longer an Exception? 72
Guiding treatment selection with immunotherapy compared to targeted therapy agents in patients with metastatic kidney cancer 68
Clinical consideration for choosing combination therapies in advanced non-small-cell lung cancer: Age, Eastern Cooperative Organization performance status 2, steroids and antibiotics 64
The dilemma of neoadjuvant and adjuvant therapy in urothelial carcinoma: Will immunotherapy solve the problem? 59
Carboplatin, nab-paclitaxel plus atezolizumab in Impower 130 trial: New weapons beyond controversies 54
Totale 2.731
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.160
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.160
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202152 0 0 0 0 0 0 0 0 0 0 0 52
2021/2022117 5 0 3 3 6 4 3 12 12 10 42 17
2022/2023333 12 23 9 16 36 19 19 22 87 12 28 50
2023/2024145 24 25 16 11 11 37 0 6 2 7 4 2
2024/2025542 33 59 45 49 74 24 25 17 12 36 52 116
2025/20261.458 137 135 92 115 207 59 134 41 282 91 65 100
Totale 2.731